8.7406
price up icon1.28%   0.1106
after-market After Hours: 8.65 -0.0906 -1.04%
loading
Redhill Biopharma Ltd Adr stock is traded at $8.7406, with a volume of 46,658. It is up +1.28% in the last 24 hours and up +2.83% over the past month. Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
See More
Previous Close:
$8.63
Open:
$8.63
24h Volume:
46,658
Relative Volume:
0.15
Market Cap:
$11.07M
Revenue:
$35.75M
Net Income/Loss:
$11.57M
P/E Ratio:
-2.296
EPS:
-3.8069
Net Cash Flow:
$-26.25M
1W Performance:
-11.89%
1M Performance:
+2.83%
6M Performance:
-34.02%
1Y Performance:
-31.45%
1-Day Range:
Value
$8.5001
$8.95
1-Week Range:
Value
$8.5001
$10.32
52-Week Range:
Value
$6.425
$82.00

Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile

Name
Name
Redhill Biopharma Ltd Adr
Name
Phone
-
Name
Address
-
Name
Employee
53
Name
Twitter
@RedHillBio
Name
Next Earnings Date
2024-09-16
Name
Latest SEC Filings
Name
RDHL's Discussions on Twitter

Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-31-21 Initiated Cantor Fitzgerald Overweight
May-18-21 Initiated H.C. Wainwright Buy
Sep-11-20 Initiated BTIG Research Buy
Jul-12-19 Upgrade WBB Securities Buy → Strong Buy
Mar-12-19 Upgrade WBB Securities Speculative Buy → Buy
Jan-26-18 Initiated Nomura Buy
Oct-06-17 Initiated Seaport Global Securities Buy
Oct-04-17 Reiterated H.C. Wainwright Buy
Feb-24-17 Reiterated FBR & Co. Outperform
Jul-27-16 Reiterated FBR Capital Outperform
Sep-29-15 Initiated Nomura Buy
Jul-29-15 Reiterated ROTH Capital Buy
Jun-17-15 Reiterated H.C. Wainwright Buy
Jun-15-15 Reiterated ROTH Capital Buy
View All

Redhill Biopharma Ltd Adr Stock (RDHL) Latest News

pulisher
Sep 09, 2024

RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines - StockTitan

Sep 09, 2024
pulisher
Sep 09, 2024

RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines - Yahoo Finance

Sep 09, 2024
pulisher
Aug 27, 2024

Can Redhill Biopharma Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Aug 27, 2024
pulisher
Aug 26, 2024

RDHL stock’s current quarter earnings estimates: What analysts predict? - US Post News

Aug 26, 2024
pulisher
Aug 21, 2024

Talicia® Launched in the United Arab Emirates - StockTitan

Aug 21, 2024
pulisher
Aug 21, 2024

Talicia® Launched in the United Arab Emirates - Yahoo Finance

Aug 21, 2024
pulisher
Aug 20, 2024

Taking on analysts’ expectations and winning: Redhill Biopharma Ltd. ADR (RDHL) - SETE News

Aug 20, 2024
pulisher
Aug 20, 2024

Redhill Biopharma stock hits 52-week high of $8.03 amid volatility - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Redhill Biopharma stock hits 52-week high of $8.03 amid volatility - Investing.com India

Aug 20, 2024
pulisher
Aug 20, 2024

Opaganib shows promise in obesity, diabetes treatment - Investing.com India

Aug 20, 2024
pulisher
Aug 19, 2024

Opaganib shows promise in obesity, diabetes treatment - Investing.com

Aug 19, 2024
pulisher
Aug 19, 2024

Balance Sheet Breakdown: Redhill Biopharma Ltd. ADR (RDHL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Aug 19, 2024
pulisher
Aug 19, 2024

Redhill Biopharma Ltd. ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Aug 19, 2024
pulisher
Aug 16, 2024

Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo Finance

Aug 16, 2024
pulisher
Aug 14, 2024

Its Stock Has Paid Off Big Time For Teck Resources Ltd - SETE News

Aug 14, 2024
pulisher
Aug 14, 2024

Are Smart Investors Making the Right Decision? Redhill Biopharma Ltd. ADR (RDHL) - SETE News

Aug 14, 2024
pulisher
Aug 14, 2024

Check Out Aveanna Healthcare Holdings Inc (AVAH)’s Trade Data Rather Than the Analysts’ Views - SETE News

Aug 14, 2024
pulisher
Aug 14, 2024

RDHL’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle

Aug 14, 2024
pulisher
Aug 12, 2024

Can you now get a good deal on Redhill Biopharma Ltd. ADR’s shares? - US Post News

Aug 12, 2024
pulisher
Aug 07, 2024

Is ThredUp Inc (TDUP) positioned for future growth? - SETE News

Aug 07, 2024
pulisher
Aug 07, 2024

A look into Redhill Biopharma Ltd. ADR (RDHL)’s deeper side - SETE News

Aug 07, 2024
pulisher
Aug 07, 2024

Immuneering Corp (IMRX) expanding its growth trajectory ahead - SETE News

Aug 07, 2024
pulisher
Aug 07, 2024

Cipher Mining Inc (CIFR) is looking forward to a strong quarter - SETE News

Aug 07, 2024
pulisher
Aug 07, 2024

Nothing is Better Than Hut 8 Corp (HUT) stock at the moment - SETE News

Aug 07, 2024
pulisher
Aug 07, 2024

Analytical Overview: Redhill Biopharma Ltd. ADR (RDHL)’s Ratios Tell a Financial Story - The Dwinnex

Aug 07, 2024
pulisher
Aug 06, 2024

Redhill Biopharma Ltd. ADR [RDHL] Revenue clocked in at $35.52 million, down -68.49% YTD: What’s Next? - The DBT News

Aug 06, 2024
pulisher
Aug 01, 2024

Redhill Biopharma Ltd. ADR Inc. (RDHL) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Aug 01, 2024
pulisher
Aug 01, 2024

Should investors be concerned about RDHL’s high price-to-sales ratio? - US Post News

Aug 01, 2024
pulisher
Aug 01, 2024

Exact Sciences Corp. (EXAS) Stock: A Year of Decreases and Increases - The InvestChronicle

Aug 01, 2024
pulisher
Aug 01, 2024

New Outlook On Alibaba Group Holding Ltd ADR - Stocks Register

Aug 01, 2024
pulisher
Aug 01, 2024

Baker Hughes Co (NASDAQ: BKR) Up 1.26%: This Is What Analysts Are Now Forecasting - Stocks Register

Aug 01, 2024
pulisher
Jul 24, 2024

Redhill Biopharma Ltd. ADR (RDHL) requires closer examination - US Post News

Jul 24, 2024
pulisher
Jul 24, 2024

Redhill Biopharma Ltd. ADR (RDHL) Stock: A Year of Market Fluctuations - The InvestChronicle

Jul 24, 2024
pulisher
Jul 23, 2024

Ratio Examination: Redhill Biopharma Ltd. ADR (RDHL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Jul 23, 2024
pulisher
Jul 22, 2024

RedHill Biopharma finalizes agreement to enhance cash position - Investing.com India

Jul 22, 2024
pulisher
Jul 22, 2024

RedHill Biopharma finalizes agreement to enhance cash position - Investing.com

Jul 22, 2024
pulisher
Jul 04, 2024

Redhill Biopharma Ltd. ADR (RDHL)'s stock performance: a year in review – US Post News - US Post News

Jul 04, 2024
pulisher
Jun 30, 2024

RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation - Yahoo Lifestyle UK

Jun 30, 2024
pulisher
Jun 20, 2024

Ratio Analysis: Unpacking Redhill Biopharma Ltd. ADR (RDHL)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

Jun 20, 2024
pulisher
Jun 20, 2024

Should investors be concerned about Redhill Biopharma Ltd. ADR (RDHL)? – US Post News - US Post News

Jun 20, 2024
pulisher
Jun 06, 2024

RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study - Yahoo News UK

Jun 06, 2024
pulisher
May 30, 2024

Emerging Technologies in the Proton Pump Inhibitors Market to Hit US$ 3.5 Billion by 2031 - openPR

May 30, 2024
pulisher
May 17, 2024

The Psychology of Redhill Biopharma Ltd. ADR Inc. (RDHL) Price Performance: Understanding Market Sentiment - The InvestChronicle

May 17, 2024
pulisher
May 03, 2024

Proton Pump Inhibitors Market In-depth Analysis, Rising Business Opportunities And Estimated Forecast Till 2031 ... - openPR

May 03, 2024
pulisher
Apr 15, 2024

Redhill Biopharma Ltd. ADR (RDHL) requires closer examination – US Post News - US Post News

Apr 15, 2024
pulisher
Apr 02, 2024

RedHill Biopharma secures $1.25 million in direct offering By Investing.com - Investing.com

Apr 02, 2024
pulisher
Mar 28, 2024

KALA Stock Quote Price and Forecast - CNN

Mar 28, 2024
pulisher
Mar 11, 2024

RedHill secures new US patent for H. pylori treatment Talicia - Investing.com

Mar 11, 2024
pulisher
Jan 25, 2024

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 - PR Newswire

Jan 25, 2024
pulisher
Nov 29, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 29, 2023
pulisher
Nov 27, 2023

RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 - Yahoo Finance

Nov 27, 2023

Redhill Biopharma Ltd Adr Stock (RDHL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$109.75
price up icon 2.23%
$73.17
price down icon 0.18%
$60.57
price up icon 0.40%
$115.22
price up icon 0.14%
drug_manufacturers_specialty_generic RDY
$79.45
price down icon 0.28%
$11.61
price up icon 0.52%
Cap:     |  Volume (24h):